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METABOLIC EVALUATION IN PEDIATRIC RENAL   STONE 
FORMERS 
                  ABSTRACT 
BACKGROUND: 
Renal stones, though not very common in pediatric population, remains a 
serious health issue in them. Metabolic causes can be found in majority of children 
with urolithiasis. By identifying the exact cause, we would be able to prevent 
recurrences and the development of end stage renal disease. Thus the aim of the 
study is to identify metabolic factors leading on to stone disease by analyzing the 
24 hour urinary metabolic parameters. 
METHODOLOGY: 
 50 children with urolithiasis are subjected to metabolic evaluation 
involving renal function test, serum uric acid, vitamin D, parathyroid hormone, 
calcium, phosphorus, alkaline phosphatase, urine pH, urine routine, urine culture, 
urine sodium nitroprusside test, 24 hour urine calcium, oxalate, citrate and uric 
acid. arterial blood gas analysis is done for children with suspicion of distal renal 
tubular acidosis.  
RESULTS : 
Out of the 50 children with urolithiasis, hyperoxaluria was present in 26 
children (12- isolated and 14- mixed abnormalities). Hypercalciuria was present in 
16 children( 4 - isolated and 12- mixed). No metabolic abnormality could be 
identified in just 3 children. Distal RTA was diagnosed in 2 children who had 
nephrocalcinosis with normal anion gap metabolic acidosis with high urine pH. 
None of the patients had cystine/ struvite stones. 
CONCLUSION: 
24 hour urine metabolic workup is the gold standard in metabolic evaluation 
of patients with urolithiasis. Hyperoxaluria followed by Hypercalciuria and 
Hyperuricosuria were the most common metabolic abnormalities detected in our 
patients. Thus early detection and treatment of metabolic abnormality must be 
stressed upon to prevent recurrences and development of end stage renal disease. 
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INTRODUCTION 
 
Renal stones, though not very common in pediatric 
population, remains a serious health issue in them. It is a painful and 
costly disease which may have detrimental long-term effects on renal 
function. As opposed to the adult patients, urolithiasis in pediatric 
population is more likely attributable to a metabolic abnormality.      
  
The incidence of urolithiasis in children is very much in 
the increasing trend at present, thanks to the recent recognition of varied 
presentations of stone disease that is different from adults, liberal use of 
improved radiographic techniques and advances in medical facilities that 
have resulted in survival through childhood and adolescence of increasing 
number of patients with conditions like cystic fibrosis that are associated 
with urolithiasis. 
 
EPIDEMIOLOGY OF UROLITHIASIS IN CHILDREN :  
Urolithiasis is a significant cause of morbidity and 
mortality in children and adolescents, accounting for 1 in 1000 to 1 in 
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7800 hospital admissions [1]. This rate is nearly 1/50th of that reported in 
adults [2]. The possible reason for the lesser incidence of urolithiasis in 
children is due to the presence in the children of very high concentrations 
of urinary inhibitors like citrate, magnesium and other macromolecules 
when compared to adults [3] 
Similar to adults, children and adolescents with 
urolithiasis also tend to show an increased male preponderance [4,5] , but 
the male to female ratio is 1.4-2.1:1 in children, in contrast to 3:1 in 
adults. Regional variations in dietary intake, climatic conditions, fluid 
intake and genetic factors are known to influence the prevalence of renal 
stones, thus stressing the need for regional studies to identify the most 
commonly prevalent abnormality in one’s own population.  
 
ANATOMIC LOCATION OF THE STONE : 
About 60 - 80% of urinary tract calculi in children are 
present in the kidneys at the time of diagnosis. The majority of the stones 
found in ureter, bladder and urethra have also originated in the kidneys. 
The bladder appears to be the site of stone formation in less than 10% in 
North America. 
In India, endemic bladder stones are found, where the 
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bladder calculi are more often seen. A diet rich in whole–grain cereals, 
animal proteins, phosphates, oxalate rich vegetables with low calcium 
diet is believed to be responsible. [6,7] The resulting urinary profile favors 
precipitation of calcium oxalate, and ammonium acid urate, the most 
frequently encountered constituents of endemic bladder stones. 
 
              
 
          FIG 1 : Plain Xray of a 6 year old boy showing vesical calculus 
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PATHOGENESIS OF UROLITHIASIS : 
Urinary stones develop usually as a result of the 
breakdown of a delicate balance between solubility and precipitation of 
solutes. The kidneys should conserve water, but they must also excrete 
materials that have a low solubility. It is these two opposing requirements
that must be balanced during adaptation to diet, activity and climate. The 
problem is mitigated to some extent by the presence of some substances 
that inhibit crystallization in urine. These protective mechanisms are not 
very perfect. So, when the urine becomes supersaturated with insoluble 
substances, because excretion rates are high and/or because water 
conservation is extreme, crystals may form, grow and aggregate to form a 
calculus. 
 
SUPERSATURATION : 
A solution which is in equilibrium with crystals of calcium 
oxalate is said to be saturated with regard to calcium oxalate. If calcium 
oxalate crystals are removed, and if either calcium or oxalate ions are 
added to the solution, it will be found that the chemical activities 
increase, but no new crystals form. Such a solution is said to be 
Introduction 
 
 
5 
 
‘metastably supersaturated’. If now, calcium oxalate crystals are added, 
the crystals will grow in size. Ultimately, as calcium or oxalate is added 
to the solution, supersaturation reaches a critical value at which a solid 
phase begins to develop spontaneously. This value is called the ‘upper 
limit of metastability’. On average, kidney stone growth requires urine 
that is supersaturated. Excessive supersaturation is commonly found in 
stone formers. 
Calcium, phosphate and oxalate form many soluble 
complexes among themselves and with other substances in urine like
citrate. Because of this, their free ion activities are well below their 
chemical concentrations. Reduction in substances like citrate can increase 
supersaturation by increasing the ion activity.  
Urine supersaturation can be increased by  
 Decreased urine volume 
 Increased excretion of calcium, oxalate, phosphate, 
cystine, or uric acid. 
 Decreased level of inhibitors like citrate, Magnesium, 
osteopontin etc. 
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                                                  Nuclei form, grow,  
UNSTABLE ZONE                                   
                                                  aggregate into crystals 
 
 
 
 
Metastable upper limit                           First crystals form 
 
 
 
 
METASTABLE ZONE                          New nuclei do not form 
 
 
Equilibrium point(SS=1)                         Crystals neither grow  
                                                   Nor dissolve 
 
UNDERSATURATED                             New nuclei donot  
ZONE(SS<1)                                       form. Added nuclei                      
                                                     dissolve 
 
 
 
Fig 2 : Supersaturation ( SS ) of urine 
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Urine pH is also an important determinant of stone 
formation.  Acids like phosphate and uric acid dissociate readily over the 
physiologic range of urine pH. Below a urine pH of 5.5, uric acid crystals
are predominantly seen whereas phosphate crystals are rare. Alkaline 
urine contains more dibasic phosphate which favour the deposition of 
brushite (CaHPO4H2O) and apatite (Ca5(PO4)3OH). Urine pH has no 
influence over the solubility of calcium oxalate 
 
FIG 3: MAJOR URINARY ABNORMALITIES ASSOCIATED 
WITH STONE 
Type Of Stone Former pH Component 
Cystine  Acid  Cystine excess 
Uric acid Acid Relative uric acid excess 
Calcium phosphate Alkaline Relative calcium excess 
Calcium oxalate 
    Idiopathic                                       
     
 
    Hyperoxaluric  
pH range of normal urine 
 
Calcium and oxalate  
excess 
 
Oxalate excess 
Renal tubular acidosis Alkaline  Calcium and phosphate 
excess 
Magnesium ammonium  
Phosphate Very alkaline 
Relative magnesium,  
ammonium and  
phosphate excess 
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CRYSTALLIZATION : 
When urinary supersaturation exceeds the upper limit of 
metastability, nucleation of crystals begin. Cell debris present in the 
urinary tract serve as templates for crystal formation. This process is 
known as heterogeneous nucleation. Heterogeneous nucleation reduces 
the level of supersaturation that is required for crystal formation. Once 
formed, crystal nuclei tend to grow in size if urine is supersaturated with
that crystal phase.  Following this aggregation of multiple crystals occur 
to form a stone. 
For a kidney stone to develop, crystals must first be 
retained in the renal pelvis for a sufficiently long time for it to grow and 
aggregate to a significant size. The mechanism of crystal retention is 
always a matter of much debate. It is shown in recent studies that 
common calcium oxalate kidney stones form as overgrowths on the 
apatite stones (sub-epithelial plaques of calcium phosphate) in the renal 
papillae. These plaques, called Randall's plaques, establish an excellent 
surface for nucleation of calcium oxalate salts. [9]These plaques arise first
in the deep medulla in the basement membrane of the thin limb of
Henle’s loop and then spread to the basement membrane of the papillary 
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urothelium. In case the urothelium becomes damaged, the plaque is 
exposed to the supersaturated urine, and crystallization and stone 
formation occurs. 
 
 
 
 
 
           
               
 
 
 
 
  
 
 
 
 
  Saturation 
Supersaturation 
  Nucleation 
Crystal growth 
and aggregation 
Crystal retention 
Stone formation 
Fig 4 :  Progression of lithogenesis  
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INHIBITORS OF CRYSTAL FORMATION : 
Urine contains very potent inhibitors of nucleation, 
growth, adhesion and aggregation for calcium salts. Inorganic 
pyrophosphate is a potent inhibitor that inhibits formation of apatite 
crystals more than calcium oxalate crystals. Citrate though inhibits the 
crystal growth and nucleation, most of its stone inhibitory activity is due 
to lowering of urine supersaturation through complexation of calcium.  
 
CLINICAL PRESENTATION OF URINARY TRACT CALCULI: 
Symptoms of renal colic and hematuria, characteristic of 
urolithiasis in adults, are less often seen in children. Abdominal pain or 
hematuria  are the most common presenting features in children with 
renal stones. In infants and toddlers, non specific abdominal pain is 
commoner than a typical renal colic. Indeed, in nearly half of the patients 
below the age of 5 years, the diagnosis of renal stones is made following 
a urinary tract infection or as an incidental finding during evaluation of 
other problems. [4]  
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STONE COMPOSITION : 
Compared to adults, pediatric renal stone formers are more 
often associated with metabolic abnormalities. The common causes of 
renal stones in adults include calcium stones (75- 85%), uric acid stones 
(5-10%), struvite (5-10%), cystine stones (1%). Out  of the calcium 
stones, 50-55% is due to idiopathic hypercalciuria, 20% is due to 
hyperuricosuria, 3-5% due to primary hyperparathyroidism, 10-30% due 
to hyperoxaluria (mainly dietary), idiopathic 20%. 
In children, the various stones formed in upper urinary 
tract are as follows. 
 Calcium stones - 70-85 % 
 Struvite stones - 10-20% 
 Cystine - 2-4 %  
 Uric acid - 2-8% 
 
CALCIUM STONES :  
Calcium stones contain calcium oxalate or calcium 
phosphate or calcium oxalate and uric acid, or calcium oxalate and 
phosphate as constituents. The different causes for calcium stones include  
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 Hypercalciuria  
 Hyperoxaluria 
 Hyperuricosuria 
 Primary hyperparathyroidism 
 Distal renal tubular acidosis. 
 
HYPERCALCIURIA: 
Hypercalciuria, as defined as the urinary calcium 
excretion of  > 4mg/kg/day, is a common cause of renal stones in 
children. Physiologic hypercalciuria is related to the dietary excess of 
sodium, protein, or calcium or to the deficiencies of potassium or 
phosphorus. 
Most hypercalciuria is idiopathic. The mechanism 
implicated in idiopathic hypercalciuria include the following . 
 Renal tubular phosphate leak 
 Increased 1,25 dihydroxy vitamin D synthesis 
 Increased renal prostaglandin E2 production 
 Enhanced bone resorption.[10,11] 
If hypercalciuria is detected, the patient must be placed in 
the proper category of causation of hypercalciuria. Four major causes 
exist.  
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TYPES FOR HYPERCALCIURIA : 
TERM PRESUMED CAUSE 
Intestinal hyperabsorption Excessive intestinal absorption of calcium 
Renal leak Failure of kidney to reabsorb tubular calcium 
Bone resorption Excessive calcium mobilised from bone 
Carbohydrate load Form of renal leak 
 
GENERAL ASPECTS OF SEPARATION OF 
HYPERCALCIURIAS 
TYPE OF 
HYPERCALCIURIA 
S.Calcium Urine 
Cyclic 
AMP 
S. 
PTH 
Fasting 
Urine 
Calcium 
Bone  
Density 
Intestinal 
Absorption 
Primary 
hyperparathyroidism 
(bone resorption) 
 
 
    
low 
 
 
Renal stones, 
absorptive 
 
N 
 
N or low 
 
N or 
low 
 
N 
 
N 
 
Renal stones, “renal 
leak” 
 
N 
    
? 
 
N 
Renal stones, 
normocalciuric 
 
N 
 
N 
 
N 
 
N 
 
N 
 
N 
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CAUSES OF HYPERCALCIURIA : 
 
NORMOCALCEMIC 
HYPERCALCIURIA 
 Idiopathic hypercalciuria 
 Distal renal tubular acidosis 
 Diuretic induced 
 Dent disease 
 Barter syndrome 
 Familial hypomagnesemia and 
hypercalciuria syndrome 
 
HYPERCALCEMIC 
HYPERCALCIURIA 
 Primary hyperparathyroidism 
 Immobilisation 
 Cushing syndrome 
 Adrenal insufficiency 
 Metastatic bone disease 
 
INTESTINAL ABSORPTION 
OF CALCIUM 
 Hypervitaminosis D or A 
 Sarcoidosis 
 Idiopathic hypercalcemia of 
childhood 
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GENETIC CAUSES OF HYPERCALCIURIA : 
 PROXIMAL TUBULE : 
         Dent’s disease  
         Hereditary hypophosphatemic rickets with hypercalciuria,  
         Lowe syndrome)  
 
THICK ASCENDING LOOP OF HENLE : 
         Bartter syndrome 
         Activating mutations of the calcium sensing receptor gene 
         Familial hypomagnesemia with hypercalciuria, 
         Nephrocalcinosis due to claudin 16 gene mutation  
 
DISTAL TUBULE : 
         Pseudohypoaldosteronism type II  
         Primary renal distal renal tubular acidosis   
 
Secondary forms of hypercalciuria may occur due to 
intake of drugs like furosemide or carbonic anhydrase inhibitors, or due 
to prolonged immobilisation, or high intake of calcium or vitamin D, or 
high concentrations of circulating PTH. Hypercalcemia of any cause may 
result in hypercalciuria. 
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HYPEROXALURIA : 
Hyperoxaluria may be inherited or acquired.  
PRIMARY  Type I 
 Type II 
SECONDARY  Malabsorption syndromes like cystic fibrosis, 
inflammatory bowel disease, short bowel 
syndrome 
 Lack of intestinal oxalate degrading 
bacteria[13,14] 
 
Primary hyperoxaluria is an autosomal recessive disorder 
caused due to the inborn error of glycine metabolism. It is of two 
types-type 1 and type 2. 
 
TYPE I  PRIMARY HYPEROXALURIA : 
Type 1 primary hyperoxaluria  is an autosomal recessive 
disease caused due to the mutations of the AGXT gene. This type 
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accounts for majority of children with primary hyperoxaluria. This is due 
to the deficiency of  alanine glyoxylate aminotransferase, an enzyme 
which is expressed only in liver  and  it requires pyridoxine  as its 
cofactor. 
 
   ETHYLENE GLYCOL 
 
 
     
 
 
 GLYCOLIC ACID                                       GLYCINE 
                                             
                              B6                   
                                
                                    
             
                                       
              
                             ALANINE      PYRUVATE 
 
 
GLYOXYLIC ACID 
 
 
               
 
               OXALIC ACID        ASCORBIC ACID            
FIG 6:  Metabolic pathway affected in primary hyperoxaluria 
TYPE I HYPEROXALURIA 
TYPE II HYPEROXALURIA 
 OXALIC  ACID 
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In the absence of this enzyme, conversion of glyoxylic 
acid to glycine cannot occur and it gets transferred to the cytosol and get 
oxidized to oxalic acid. Renal failure is common in children with type I 
primary hyperoxaluria.  
 
DIAGNOSIS : 
1. Marked hyperoxaluria 
2.  ↑ Urinary excretion of  glyoxylic acid  &  glycolic acid 
3. Enzyme assay in liver specimens  
4. Mutant gene identification. 
 
TYPE II  PRIMARY HYPEROXALURIA : 
Type 2 primary hyperoxaluria is due to deficiency of 
cytosolic enzyme glyoxylate reductase/hydroxyl pyruvate reductase. As a 
result of the deficient enzyme activity, the level of L-glyceric acid and 
oxalic acid increase and they are thus eliminated by the kidney. Renal 
failure is less in this condition.   
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DIAGNOSIS : 
1. Marked hyperoxaluria 
2. ↑ urine L-glyceric acid (with normal urine glycolic and glyoxylic 
acid levels) 
3. Enzyme assay in liver specimens  
4. Mutant gene identification 
 
ENTERIC HYPEROXALURIA: 
Enteric hyperoxaluria is the condition resulting from 
increased absorption of oxalate from intestine. Fat malabsorption and thus 
the conditions causing it, can result in hyperabsorption of oxalate from 
intestine. The reason behind this is the binding of calcium with the fatty 
acids in the intestine, thereby resulting in less calcium availability in the 
lumen for oxalate to which in turn gets  absorbed  readily.  
 
OXALOBACTER FORMIGENES AND OXALATE STONES : 
Recently, it has been identified that  the degradation of 
fecal oxalate by some anaerobic  bacteria that colonise the colon occurs 
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in  a significant proportion of healthy population . The loss of such 
bacteria, like Oxalobacter formigenes is attributed to the increased 
absorption of oxalate  from the gut and thus the formation of oxalate 
stones.[15] 
 
HYPOCITRATURIA : 
There are some naturally occurring inhibitors of stone 
formation. They are as follows. 
1. Citrate 
2. Pyrophosphate 
3. Magnesium 
4. Urinary macromolecules 
 Glycosaminoglycans 
 Osteopontin 
 urinary prothrombin fragments  
Deficiency of citrate may be idiopathic or due to drug 
intake. In distal RTA, hypocitraturia is the main contributor for stone 
formation. 
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CYSTINE STONES :     
Cystine stones are due to an inherited error of defective 
transport of cystine, and dibasic aminoacid such as lysine, ornithine, and 
arginine across intestinal and renal tubular cell membranes. Characteristic 
hexagonal shaped crystals can be seen in urine of patients with cystinuria. 
It is of two types -  type  I  and  type  II. 
 
TYPE I CYSTINURIA : 
        In type I cystinuria, the mutation is in the SLC3A1 gene on 
chromosome 2 and the urinary excretion of cystine is normal in 
heterozygotes[18,19].  It is inherited as autosomal recessive trait. 
 
TYPE II CYSTINURIA :          
In type 2 cystinuria, the mutation is in SLC7A9 gene on 
chromosome 19 , where the urinary excretion of cystine is moderately 
elevated in heterozygotes and much higher in homozygotes[20]. It is 
inherited as a dominant trait with incomplete penetrance.  
 
Urine sodium nitroprusside test, a sensitive screening test 
for cystinuria is done in all patients with urolithiasis.  Cystine stones are 
radio-opaque stones of intermediate density in radiographic imaging. If 
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cystine stones (characteristic hexagonal shaped cystine crystals ) are 
positive in stone analysis or if the family history of cystinuria is present, 
then urine amino acid chromatography can be done to confirm the 
diagnosis of cystinuria.  
     
STRUVITE STONES : 
Struvite stone or infection stone occurs following infection 
with urease producing organisms, which split urea with resultant 
production of ammonium and bicarbonate ions. By this way the ph rises 
and in alkaline ph, phosphate dissociation occurs, resulting in the 
supersaturation of urine magnesium ammonium phosphate and calcium 
phosphate apatites.[21] 
Struvite stones tend to form the staghorn calculus that 
grow rapidly and are difficult to treat. Uric acid stones are relatively 
uncommon in children.                  
                             BACTERIAL UREASE 
NH2 CO NH2(urea) + H2O                        2 (NH3) +H2CO3 
 
2 NH3 +H2O                   NH4+ OH 
 
 (FIG 7: Production of ammonium by the action of bacterial urease on 
urea.because of excess of NH4 ,the urine remains alkaline even if the 
renal excretion of acid is normal) 
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FIG 8 : Factors in the formation of magnesium ammonium phosphate 
calculi related to persistent alkaline urine. 
 
Xanthogranulomatous pyelonephritis is a serious 
infectious condition affecting leading to non function of affected 
kidney[22]. A kidney damaged by calculi may be the site of replacement 
lipomatosis (xanthogranulomatous pyelonephritis). Organisms causing 
xanthogranulomatous pyelonephritis include the list below.[23] 
 Proteus 
 
 Klebsiella 
 
 Staphylococcus 
 
 pH> 7.2 
Urine supersaturated with 
phosphate 
 
pH< 6.8 
Urine undersaturated with 
phosphate 
Stone  forms 
Stone dissolves 
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 Pseudomonas 
 
 Enterobacter 
 
 Ureaplasma urealyticum 
 
 Providentia 
 
In xanthogranulomatous pyelonephritis, infection, 
obstruction, and urolithiasis form a vicious cycle and complicate each 
other.  
 
URATE STONES : 
 
Hyperuricosuria may be primary or secondary. Idiopathic 
renal hyperuricosuria is often familial and asymptomatic. Mild idiopathic 
hperuricosuria may cause hematuria in some individuals[24]. Secondary 
hyperuricosuria may be a result of 
 
 High protein diet 
 
 High  ketogenic diet 
 
 Medications like ascorbic acid, dicumarol, probenicid, salicylates, 
citrate 
Studies have documented the presence of secondary 
hyperuricosuria in patients with diabetes mellitus type 1 [25]. 
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Hypouricemia and hyperuricosuria have also been reported to occur in 
patients with syndrome of inappropriate anti diuretic hormone 
secretion[26]. 
Uric acid stones, as such, are uncommon in childhood. 
When they are found in children, it is almost always due to the marked 
overproduction of uric acid in any one of the conditions listed below. 
 Lymphoproliferative disorders 
 Tumor lysis syndrome 
 Inborn Errors of  Metabolism - Lesch Nyhan 
syndrome ( due to deficiency of hypoxanthine guanine 
phosphoribosyl transferase) 
 Glycogen storage disease (Von Gierke’s, 
Forbe-Cori’s, Mc Ardle , Tauri disease ) 
 
XANTHINE CALCULI : 
Xanthine calculi may be found in patients treated with 
allopurinol for hyperuricemia caused due to tumor lysis syndrome or 
Lesch Nyhan syndrome[27]. They are also seen in patients with autosomal 
recessive deficiency of xanthine oxidase or in patients with hereditary 
xanthinuria   
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OTHER SOLUTE EXCESS : 
Rare inborn errors of metabolism causing urolithiasis 
include orotic aciduria, alkaptonuria ,adenine phosphoribosyl transferase 
deficiency[28,29} 
CLINICAL CONDITIONS ASSOCIATED WITH UROLITHIASIS: 
UROLITHIASIS AND RENAL TUBULAR ACIDOSIS :  
DISTAL RTA: 
Impaired acidification of urine, leading on to calcium 
stones, due to the reduced solubility of calcium in alkaline medium as 
well as metabolic acidosis, is the case in distal renal tubular acidosis. 
 
Distal RTA results in hypercalciuria, hypocitraturia,low 
titratable acidity and high urine pH. Nephrocalcinosis due to calcium 
phosphate and /or calcium oxalate stones are characteristic and is seen 
with both complete and incomplete types of distal RTA[30].  
 
Ammonium chloride loading test is useful in cases of 
incomplete forms to confirm the diagnosis of distal renal tubular acidosis. 
Failure of the urine to acidify even in the presence of acid load is 
diagnostic.  
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Secondary distal RTA due to Wilson’s disease, Sjogren’s 
Syndrome, type I GSD, cerebrotendinous xanthomatosis are also 
associated with urolithiasis. 
 
PROXIMAL RTA: 
Despite the occurrence of hypercalciuria in proximal renal 
tubular acidosis, urolithiasis is not usually found in these patients. It is 
attributed to the presence of high amount of citrate that may protect 
against stone formation[31] 
 
TYPE IV RTA :          
Urolithiasis is not usually associated with type IV RTA 
also. It is because the reduced excretion of calcium appears sufficient to 
compensate for the reduced citrate excretion, so that the urinary 
saturation of calcium oxalate remains within normal limits. Low uric acid 
and phosphorus excretion in these patients appear to mitigate against 
stone formation[32]. 
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OBESITY AND METABOLIC SYNDROME : 
Insulin resistance results in impaired renal ammonia 
production. Owing to the low urine ph, uric acid stone formation 
occurs[33]. In addition, the bariatric procedures performed during the 
treatment of obesity are associated with hyperoxaluria. 
 
 
STRUCTURAL ABNORMALITIES OF URINARY TRACT: 
 
 Medullary sponge kidney [34] 
 
 Thin basement membrane nephropathy 
 
 Posterior urethral valves 
 
 Horse shoe kidney 
 
 Ureterocele 
 
 Primary megaureter  
 
 Bladder extrophy- epispadius complex 
 
 Autosomal dominant polycystic kidney disease [35] 
 
PREMATURITY :  
 
 Preterm babies have higher incidence of 
nephrolithiasis and nephrocalcinosis when compared to healthy term 
babies. The following preterm babies are at high risk.[36] 
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 Extremely low birth weight babies. 
 
 Those receiving furosemide 
 
 Those receiving  postnatal corticosteroids 
 
 Longer duration of mechanical ventilation 
 
 Parenteral nutrition 
 
 Family history of nephrolithiasis 
 
             
INFLAMMATORY BOWEL DISEASE : 
              
Inflammatory bowel disease, and other diseases with 
associated malabsorption, can lead to hypocitraturia and hypomagnesuria 
due to the loss of  bicarbonate and magnesium in stools. They also cause 
increased absorption of  oxalate leading on to formation of oxalate 
stones. Due to increased cell turn over, hyperuricosuria may occur. 
Diarrhoea leading to dehydration and low urine volume may perpetuate 
stone formation[37]. 
DRUGS AND UROLITHIASIS :  
Renal excretion of some medications may exceed its 
solubility limit in urine, or may induce some metabolic changes which 
may result in stone formation. The following are some of the medications 
associated with urinary calculi formation. 
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 Indinavir (common, 2-28%)   [38] 
 
 Ceftriaxone 
 
 Sulfonamides 
 
 Amoxycillin 
 
 Triamterene 
 
 Ampicillin 
 
 Guafenesin 
 
 Phenazopyridine 
 
 Calcium, vitamin D supplements 
 
 Cyclosporine 
 
 Lithium 
 
 Orlistat 
 
 
DIET AND UROLITHIASIS :  
 
 High animal protein intake predisposes to the higher 
urine excretion of uric acid, calcium, and oxalate 
and reduced excretion of urinary citrate and reduced 
urine ph. All of these favour calcium oxalate stone 
stone formation. 
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 Intake of diet low in animal proteins but high in 
cereals lead to formation of endemic bladder stones 
in children. 
 Large intake of sodium or calcium may result in 
hypercalciuria. 
 High dietary oxalate, particularly if taken along with 
low calcium diet can lead on to hyperoxaluria. 
 Fructose intake has been associated with 
hyperuricosuria, hyperoxaluria, insulin resistance 
and low urine ph, and thus the risk of stone disease. 
 Contemporary weight loss diets like Atkins diet, 
which is rich in  animal proteins but low in 
carbohydrates are associated with urolithiasis.[39] 
 Ketogenic diet used for the management of refractory 
epilepsy is associated with nephrolithiasis. 
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CRYSTALS IN URINE MICROSCOPY: 
Microscopic examination of the spun urine can be done to 
assess for RBCs and urinary crystals. Different crystals have different 
shapes in microscopy. 
Calcium oxalate monohydrate crystals 
 
Spindle / 
oval / 
dumbbell 
shaped/ flat 
elongated 
“FENCE 
PICKET” 
crystals 
calcium oxalate dihydrate 
crystals
 
Colourless 
squares with 
intersecting 
lines 
(ENVELOPE 
like) 
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Triple phosphate (struvite) crystals 
 
Colorless, 
prism- like 
“COFFIN 
LIDS” 
Uric acid crystals 
 
 
Yellow – 
brown 
rhombic 
plates / 
needles/ 
rosettes 
Cystine crystals 
 
 
HEXAGONAL – 
shaped 
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IMAGING IN NEPHROLITHIASIS: 
PLAIN X-RAY: 
Most calculi are radio opaque and will be visible on plain 
x-ray (kidney, ureter, bladder [KUB]). But it should be understood that 
not all radio opaque shadows are stones and also that not all stones are 
radio opaque. A stone can be missed in case of bowel distension. 
 
           
 
FIG 9: Plain Xray showing left side renal calculus in a 8 year old boy 
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ULTRASONOGRAPHY: 
  Ultrasound is another method for non invasive 
exploration of the child with urolithiasis. Ureteral calculi cannot be 
detected by ultrasonography except for that at proximal or distal ureters. 
However most ureteral calculi are either proximal or distal.  
 
      
 
FIG 10 : Ultrasonogram showing right medullary nephrocalcinosis 
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ADVANTAGES: 
 
1. Wide availability 
 
2. Avoidance of ionising radiation 
 
3. Ready detection of hydronephrosis 
 
4. Detection of anatomical abnormalities 
 
 
DISADVANTAGES : 
   
1. Ultrasound is a good initial choice and in 
uncomplicated cases, it may be all that is needed. It is also the optimal 
imaging method for detecting and monitoring resolution of 
nephrocalcinosis.  
2. Not as sensitive as CT scanning in small stone 
detection and for detecting stones in ureter . 
3.  Stone size measurement is less reproducible. 
 
ULTRASOUND VERSUS KUB :  
Ultrasound is found to be more sensitive than KUB in 
diagnosing a stone (84% versus 54%). However KUB is found to be more 
sensitive for ureteral calculi. A combination of KUB and urinary tract 
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ultrasound together allow an accurate diagnosis of around 90% of urinary 
calculi. 
 
INTRAVENOUS PYELOGRAPHY :  
Intra venous pyelography is the study of choice for the 
very rare calculi seen not seen on KUB film or ultrasound, especially 
ureteral calculi. IVP provides morphologic and functional information. 
 
CT SCANNING : 
CT scan is probably the most sensitive way to detect 
urinary tract calculi. 
                 
FIG 11 : CT scan showing of a 7 year old girl showing multiple bilateral 
pelvic and calyceal calculi. 
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However, the use of CT scan should be limited in children 
to difficult cases like small and faintly opaque ureteral stones as CT 
delivers significant irradiation. 
    
NATURE AND CHARACTERISTICS OF STONE :  
The appearance of a stone on imaging studies is dependent 
on its composition. 
 
  STONE TYPE 
 
  Xray  / CT scan 
 
     DENSITY 
 
Calcium oxalate 
 
radio-opaque 
 
very dense  
 
Calcium phosphate 
 
radio-opaque 
 
very dense 
 
Struvite stone 
 
radio-opaque 
 
Intermediate density 
 
Cystine stone  
 
radio-opaque 
 
Intermediate density 
 
Uric acid stone 
 
Radiolucent 
 
Low density 
 
Indinavir stone 
 
Variable lucency 
 
Variable density 
 
FIG 13: Table showing the appearance of different stones in x-ray/ CT 
scan 
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NEPHROCALCINOSIS:  
Nephrocalcinosis denotes deposition of calcium oxalate or 
calcium phosphate in the tubulo-interstitial region of the kidney. 
Medullary nephrocalcinosis appears to be the more common pattern 
observed[8]. Nephrocalcinosis, though often seen with nephrolithiasis, 
may occur without its concurrence. Though the pathologies of the two are 
distinct, the risk factors of the two are the same [8]. It is also important to 
note that, of the two, nephrocalcinosis appear to be more commonly 
associated with renal dysfunction. 
 
Nephrolithiasis when seen with nephrocalcinosis 
particularly suggests the presence of metabolic disorder like 
hyperoxaluria or distal renal tubular acidosis.The following table (Fig 14) 
shows the common causes of nephrocalcinosis. 
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COMMON CAUSES OF NEPHROCALCINOSIS 
1. Prematurity 
2. Hypercalcemia 
3. Williams syndrome 
4. Primary neonatal hyperparathyroidism 
5. Paracellin I disorders 
6. Bartter’s syndrome 
7. Dent’s syndrome 
8. Lowe syndrome 
9. Cystinosis 
10. Distal RTA 
11. Calcium sensing receptor disorders 
12. Primary hyperoxaluria 
13. Cystic fibrosis 
14. Drugs like frusemide, dexamethasone 
15. Long term parenteral nutrition 
16. Vitamin A and D intoxication 
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FIG 15: Plain Xray KUB showing bilateral nephrocalcinosis in a 8 year 
old boy 
DIFFERENTIAL DIAGNOSIS FOR NEPHROCALCINOSIS: 
1. Acute cortical necrosis 
2. Chronic glomerulonephritis 
3. Kidney transplant rejection 
4. Pyelonephritis 
5. Renal tuberculosis 
6. Renal vein thrombosis 
7. Tamm – Horsfall deposits 
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GRADING  SCALE  FOR  MEDULLARY NEPHROCALCINOSIS 
 
 IN CHILDREN       
 
GRADE I       Mild increase in echogenicity around the border of the  
                  
                 medullary pyramids  
 
 
GRADE II      Mild diffuse increase in echogenicity of entire medullary   
                  
                 pyramid  
 
 
GRADE III     Greater, more homogenous increase in echogenicity of entire  
                 
                 medullary pyramid 
  
 
 
TREATMENT OF UROLITHIASIS :     
 
 
ACUTE MANAGEMENT OF STONE : 
 
 
 Oral or parenteral analgesics for attacks of colicky pain . 
 Calcium channel blockers and corticosteroids for facilitating                      
stone passage 
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 If there is no obstruction, large fluid administration to   
facilitate stone passage 
 Physical activity 
 If there is obstruction, further evaluation of function of the 
kidney using renal scintigraphy (MAG-3) / intravenous 
urogram may be done. 
 If obstruction persists, prompt removal of the stone to avoid 
kidney damage 
 
SURGICAL INTERVENTIONS : 
 
 INDICATIONS : 
 
 Stones more than 5 mm 
 
 Symptomatic stones 
 
Only cystine stones and uric acid stones can be dissolved 
chemically, cystine Stones by chelating agents and uric acid stones by 
alkalinizing urine and by administration of allopurinol. 
 
RENAL STONES : 
 
 Extracorporeal shock wave lithotripsy 
 
 Percutaneous nephrolithotomy 
 
 Open surgery 
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PROXIMAL URETER : 
 
 Extracorporeal shock wave lithotripsy 
 
 
DISTAL URETER : 
 
 Retrograde ureteroscopic lithotripsy with holmium : YAG 
laser 
 
 
                
              
              FIG 16: Plain Xray showing right distal ureteral calculi 
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PRIMARY BLADDER STONES : 
 
 Open surgery 
 
 Endoscopic transurethral disintegration with mechanical  
 
           cystolithotripsy 
 
Recommendations  For  Interventional  Management  In  
Pediatric stones  
Stone Size And  
Localisation 
Primary 
Treatment 
Secondary 
Treatment 
Stag horn PCNL ESWL / Open 
Pelvis <10 mm ESWL RIRS/PCNL 
Pelvis 10 – 20 mm ESWL PCNL 
Pelvis >20 mm PCNL ESWL/Open 
Lower pole calyx <10 mm ESWL RIRS/PCNL 
Lower pole calyx >10 mm PCNL ESWL 
Upper ureter stones ESWL PCNL/URS/Open 
Lower ureter stones URS ESWL/ Open 
Bladder stones Endoscopic  
 
 ( ESWL – extra corporeal shock wave lithotripsy, PCNL – percutaneous 
nephrolithotomy, URS – ureteroscopic removal of stones, RIRS- 
retrograde intrarenal surgery ) 
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SPECIFIC THERAPEUTIC AND PREVENTIVE MEASURES : 
 
HYPERCALCIURIA : 
 
NUTRITION: 
 
1. Low sodium diet 
 
2. Avoidance of high protein diet ( animal protein ) 
 
3. Avoidance of marked dietary excess of calcium ( dietary 
calcium restriction may lead to negative calcium balance, and 
furthermore leads to increased absorption of oxalate, and thus 
results in oxalate stones ) 
4. High fluid intake 
5. High fibre diet  
 
 
PHARMACOLOGIC TREATMENT : 
THIAZIDE DIURETICS : 
Thiazide diuretics reduce renal excretion of calcium and 
thus cause hypocalciuria and improve bone density. Hypokalemia which 
is a side effect of thiazide diuretic, should be carefully avoided because 
hypokalemia may lead to hypocitraturia and thus causing an inadvertent 
increase of the urinary saturation. 
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    Table : Hints at selection of patients for anticalcium stone therapy 
Serum/ urinary defect found Therapy likely to succeed 
Hypercalcemic hypercalciuria with 
high PTH 
Surgical removal of abnormal 
parathyroid  
Hypercalcemic hypercalciuria with 
hypervitaminosis D 
Stop excessive vitamin D 
Hypercalciuria , immobilisation Exercise , large fluid 
intake,avoiding excess calcium in 
diet 
Hypercalciuria,hyperthyroidism Treat hyperthyroidism 
Hypercalciuria, hperabsorption Neutral phosphates 
Hypercalciuria,renal leak Thiazides 
Relative hypercalciuria, magnesium 
deficit(Mg*100/Ca)<=33 
Magnesium oxide 
Hyperuricemia and hyperuricosuria 
with calcium urolithiasis 
Allopurinol  
Intestinal hyperabsorption, 
hyperoxaluria 
High calcium, very low oxalate 
diet plus cholestyramine 
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CITRATE : 
Potassium citrate 0.2-0.3g/kg is given in patients with 
distal RTA, which leads to reduction in calcium excretion and increase in 
urinary citrate level and serum potassium level through correction of 
metabolic acidosis 
PRIMARY HYPEROXALURIA : 
NUTRITION : 
1. High fluid intake 
2. Special dietary recommendations are not needed 
except for avoidance of extremely oxalate rich food like spinach or 
rhubarb. 
 
 PYRIDOXINE :   
High dose pyridoxine therapy of 5 – 10 mg/kg/day is 
recommended for primary hyperoxaluria type I.Trial of atleast 3 to 6 
months is warranted. Pyridoxine therapy does not appear to of help in 
primary hyperoxaluria type II.     
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CRYSTALLIZATION INHIBITORS : 
1. Citrate (0.1 – 0.2 g/kg/day ) 
2. Magnesium And Phosphate Preparations - inhibitors of calcium 
oxalate or calcium phosphate crystallization .  
 
RENAL REPLACEMENT THERAPY :  
It is needed in cases of primary hyperoxaluria  and enteric 
hyperoxaluria. In case of primary hyperoxaluria, combined hepatic and 
renal transplantation will be of beneficial. 
SECONDARY HYPEROXALURIA : 
NUTRITION : 
1. High fluid intake 
2. Avoidance of oxalate rich food like spinach, rhubarb 
3. Avoidance of excess intake of ascorbic acid (precursor 
for oxalate) 
4. Calcium supplementation 
CRYSTALLIZATION INHIBITORS: 
1. Potassium citrate 
2. Sodium potassium citrate 
3. Magnesium  
4. Neutral phosphate 
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         DIET RICH IN OXALATE 
1. Cocoa 
2. Tea  
3. Grape juice 
4. Grapefruit juice 
5. Apple juice 
6. Almond  
7. Cashew nuts 
8. Cranberries 
9. Currants 
10. Raspberries 
11. Plums 
12. Greens 
13. Rhubarb 
14. Spinach 
15. Beets 
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NEWER CONCEPT :  
A promising potential treatment awaiting clinical 
confirmation is the use of Oxalobacter formigenes, an oxalate degrading 
anaerobic microbe that normally inhabits the intestine. Lending credence 
to the importance of such bacteria, it has been observed that patients with 
secondary hyperoxaluria have  lack / absence of such bacteria.  
 
CYSTINURIA :  
1. High fluid intake (approximately 3 litres /day) 
2. Low sodium diet 
3. Alkalinization of urine 
4. Avoid protein gluttony 
5. Chelating agents : 
 D – penicillamine 
 Captopril 
 α mercapto propionyl glycine 
 Bucillamine  (+ pyridoxine) 
URATE STONES : 
1. High fluid intake 
2. Alkalinisation of urine 
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3. Avoidance of purine rich meat and excess proteins 
4. Allopurinol (xanthine oxidase inhibitor) 
STRUVITE STONES : 
1. Surgery  
2. Appropriate antibiotic therapy  
Complete removal of the stone with subsequent sterilization 
of the urinary tract is the treatment of choice for patients who can tolerate 
the procedures. Percutaneous nephrolithotomy is the preferred surgical 
procedure for most patients with struvite stones. For some patients, 
ESWL in combination with percutaneous nephrolithotomy may be used.  
Open surgery may rarely be required. To reduce recurrence after surgery, 
irrigation of renal pelvis with hemiacridin ( a solution that dissolves 
struvite) may be done.  
Appropriate antibiotic therapy must be initiated based on 
the urine culture or the culture of stone fragments removed during 
surgery. Stone-free rates of 55–90% have been reported after surgical 
intervention. 
For patients who are not candidates for surgical removal 
of  stone, acetohydroxamic acid, an inhibitor of urease, may be tried. But 
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serious side effects like headache, tremor, thrombophlebitis have limited 
its use. 
 
MEDICAL FOLLOW-UP: 
Children with stones require close follow up, with 
frequent outpatient visits atleast once every 3- 4 months because they are 
unable to adhere to the preventive measure continuously without strict 
surveillance and emotional support from family and physician. 
Compliance to preventive and therapeutic measures must be ascertained 
during every visit through biochemical urinary monitoring if possible 
crystalluria on fresh urine. 
 
FOLLOW UP IMAGING : 
Plain x-ray and USG generally provide sufficient 
information for patient follow up. They must be performed at sufficient 
intervals depending on the type of stone, causal disease and presence or 
absence of crystalluria. In the absence of symptoms or crystalluria, one 
imaging per year seems sufficient. 
IVP and CT scan can also be done to detect residual 
fragments when necessary. 
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The significance of identifying the underlying metabolic 
cause, lies in the fact that recurrence of stone can be avoided by treating 
the metabolic  abnormality and also the most dreaded complication of 
end stage renal disease could be prevented by appropriate treatment at 
appropriate time.  This can also help us and the family to understand the 
prognosis of the disease, especially in the case of inborn errors leading to 
renal stones (eg: primary hyperoxaluria), thereby aiding in avoiding the 
unnecessary time and money spent in treatment. Thus the scope of this 
study is to identify the prevalence of various metabolic parameters 
causing renal stones. 
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AIM AND OBJECTIVE 
AIM: 
To evaluate the metabolic abnormalities  in children with 
urolithiasis. 
 
OBJECTIVE: 
PRIMARY OBJECTIVE : 
To identify the metabolic parameters leading on to stone 
disease in pediatric patients  by measuring the 24 hour urinary 
calcium, oxalate, citrate and uric acid. 
 
SECONDARY OBJECTIVE : 
i) To identify the mean age of presentation of children 
with urolithiasis. 
ii) To identify the sex predilection in children with 
urolithiasis. 
iii)  To find the  incidence of family clustering of stone 
disease. 
iv) To find the most common way of presentation of 
pediatric urinary tract calculi. 
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    REVIEW OF LITERATURE 
 
The presence of stones in the urinary tract has fascinated 
medical scientists for centuries. Perhaps it is the preposterous idea that 
the human body should manufacture something so foreign and mundane 
as a stone that has caused the subject to be viewed more with humorous 
fascination than scientific erudition. In recent years, however, serious 
investigations have been conducted in the area of urolithiasis, clarifying 
some of the pathogenetic mechanisms involved in stone production. 
 
Urinary stone incidence and composition have changed 
markedly over the past decade in parallel with profound changes in life 
style and dietary habits, resulting in a dramatic rise in the occurrence of 
calcium oxalate stones. However, studies in India, evaluating the 
metabolic abnormality in urinary calculi are very scarce. 
 
In a prospective study conducted in Iran from 2005 to 
2007 to evaluate the metabolic factors associated with urinary calculi in 
children, Mitra Naseri et al., subjected 142 children with renal stones to 
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imaging studies, serum biochemical analysis and  24 hour urine analysis 
for calcium, oxalate, citrate, uric acid, magnesium and the results were as 
follows . [41]  
Hypercalciuria - 17.6% 
Hyperuricosuria - 16.1% 
Hyperoxaluria - 11.9% 
Cystinuria - 6.3% 
Hypocitraturia - 2.1% 
Mixed abnormalities - 11.2%  
               Idiopathic - 46.2% 
From their study, they concluded that calcium and uric 
acid abnormalities were the most common metabolic problems leading 
onto stone disease, and  that vesico-ureteric reflux was the most common 
anatomical abnormality causing renal calculi in their study group. 
 
  This is, by and large, in contrast to a study  done by 
Akhil Joshi et al., from Sanjay Gandhi PG institute of medical sciences, 
Lucknow [42] . They analysed 39 patients with first episode of renal 
calculi, for various parameters including serum calcium, phosphorus, 
creatinine, albumin, alkaline phosphatase, parathyroid hormone, 25 – 
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hydroxy vitamin D levels, and 24 hour urinary citrate, oxalate, calcium, 
uric acid, and ammonium chloride loading test, if at all needed (to rule 
out distal renal tubular acidosis). The following is the result of the study. 
Hypocitraturia - 82% 
Hyperoxaluria - 56%  
Hypercalciuria - 41% 
Incomplete RTA – 5% 
Idiopathic – 3%  
Considering that majority of first time renal stone formers 
have metabolic abnormality and that hypocitraturia as the most common 
one detected, they suggested that insufficency of inhibitors, especially 
citrate, is the main culprit behind the renal stones. 
 
These results were similar to that observed in a study titled 
"Twenty-Four-hour Urine Constituents in Stone Formers", conducted by 
N.S.Hussain et al., from Malaysia, in which 106 patients with renal 
calculi were included and their 24 hour urine samples were analysed for 
calcium, citrate, urate and oxalate,and they observed that the commonly 
associated  biochemical abnormalities were hypocitraturia , 
hyperoxaluria and hypomagnesuria[43]. 
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Kristin J. Bergsland et al., from the University of Chicago, 
in his study to identify the metabolic abnormalities in stone forming 
children, compared chemical measurements and crystallization properties 
of 24-hour urine samples from 129 stone forming children, with 105 
non-stone forming siblings and 183 normal, healthy children with no 
family history of stones; in age group of  6 to 17 years. They identified 
hypercalciuria  and the reduction in the gap between upper limit of 
metastability and supersaturation of calcium phosphate, as crucial 
determinants of stone risk [44] . 
 
In a retrospective study done by Afshin Safaei et al., from 
Iran, from 2004 – 2009, it was observed  in a group of 84 children that  
 
(i) Kidney is a more common site for calculi than the 
bladder. 
(ii) Most common presenting symptom observed in the 
study was dysuria, abdominal pain and restlessness 
(iii) Positive family history being a significant risk factor 
followed by urinary tract infection and structural 
abnormality 
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(iv) Normocalcemic hypercalcuria takes lead among the 
metabolic factors, followed by hyperuricosuria, 
hyperoxaluria, cystinuria [45] . 
 
Ismail Dursen et al from turkey found that out of the 179 
pediatric patients included in their study from 1998-2005, hypercalciuria 
and hyperuricosuria were detected in 42.3 and 54.8% respectively [46] . 
 
Interesting to quote here will be the results of the case 
control study done by Kumar et al from India, from 1999 to 2001. He 
stated that hypocitraturia is the most common cause for pediatric renal 
stones followed by hyperoxaluria. The study included 125 subjects, of 
whom 44 first time stone formers & 56 recurrent stone formers were 
taken as cases, and 25 healthy staff members were taken as controls. He 
found that 24 hour urinary oxalate and calcium concentration were 
consistently higher in stone formers when compared with normal 
individuals. Stone patients excreted significantly higher levels of uric 
acid. Patients with recurrent stone formation excreted significantly high 
levels of calcium (p < 0.05) and lower levels of citrate (p < 0.01) than 
patients with one episode of stone formation [47] . 
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There are significant number of studies evaluating the 
effect of age and gender on the distribution of different types of urinary 
calculi. Notable among them is a study on 27,980 renal stone patients 
(19442 males and 8538 females) by Daudon et al., from 1976 to 2001, 
who analyzed the relationship between age and sex and composition of 
stone. He found a male preponderance for calcium oxalate and urate 
stones, and female predominance for calcium phosphate and struvite 
stones, and an increasing prevalence of urate stones with age in both 
males and females [48]. 
A majority of patients with urinary calculi remain 
asymptomatic over 3–5 years follow up. In a study from Japan, it was 
observed that after a mean follow up of 33 months, 12% of Japanese 
patients who were asymptomatic, required urological management. A 
Canadian study showed that after a mean follow up of 32 months, 32% of 
Canadian patients with asymptomatic urolithiasis developed urinary colic, 
with a cumulative 5-year event probability of 48.5% [49] 
 
Novak et al., conducted an epidemiologic investigation to 
identify the sex prevalence of pediatric renal stones in united states. They 
observed that boys were more commonly affected in the first decade of 
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life and girls in the second decade [50] . The reason for this unique 
epidemiologic finding is not readily apparent necessitating the need for 
further studies in this topic. 
 
Dwyer et al., from Mayo clinic conducted a population 
based study in pediatric population to determine the incidence of 
symptomatic renal stones during a 25-year period and also to identify 
factors related to changes in stone incidence during that period . A total of 
207 children were included in the study and they observed that the 
incidence rate increased by 4% per calendar year (p value - 0.01) 
throughout the 25-year period. The exact cause of this finding could not 
be determined by this study. [51]  
 
Mohsen Akhavan et al., [52]  from Iran conducted a case 
series with 100 pediatric patients for evaluation of etiology and clinical 
manifestations of renal stones in Qom. 100 Children, younger than 14 
years old with mean age of 3.32 years, were included in the study. 54% of 
them were males. Etiology of renal stones in 5% was unclear. Metabolic 
disorders found in patients were hypocitraturia in 54 %, hyperoxaluria in 
14 %, hyperuricosuria in 25%, cystinuria in 6%, hypercalciuria in 28% 
and phosphaturia in 8% of  patients. The presenting clinical feature was 
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fever, pain, dysuria, irritability and hematuria. Family history of 
urolithiasis was found in 23% of patients. 54% of children presented with 
urinary tract infection (UTI). They concluded that majority of patients 
were symptomatic and the commonest risk factor being hypocitraturia 
among others.     
 
The incidence of renal stones is on the increase throughout 
the world. Sas et al.,[53] documented a significant increase in the incidence 
of renal stones in children between 1996 and 2007, on the basis of his 
study in the state of South Carolina. They noticed the greatest rate of rise 
in adolescents, pre-adolescents, and Caucasian children. They also found 
that infants, toddlers, and African-American children did not show 
significant increase in incidence in that period. Girls showed a growing 
predominance in their population. 
 
Stone composition and urinary metabolic stone risk 
parameters in children are distinct from those of adults. Though renal 
stone formation has a linear relation with the age of the patient, pediatric 
patients tend to form a greater percent of calcium-based stone than adults. 
On the other hand, there are fewer cases of uric acid stones in children 
than adults. The reason for this discrepancy is associated with a higher 
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urinary pH in pediatric population than in adults.  It was noted that the 
risk of childhood struvite stones has decreased, perhaps due to the 
advancements in diagnosis and management of urinary tract infections 
and management of anatomical and neurological factors associated with 
urinary infections [54] . 
 
Owing to the recent rise in incidence of childhood obesity, 
it has long been assumed that large BMI contributes to the childhood 
stone disease epidemic. A recent study by Kieran et al. however 
questions the existence of such a link in children. The authors stratified 
112 children with urolithiasis based on their BMI into patients with lower 
percentile body weight, normal weight, and upper percentile body weight. 
They observed that upper percentile body weight was not found to be 
associated with earlier stone development or larger stone size or with the 
need for multiple surgical procedures. The surgical intervention rate and 
stone size were similar regardless of body mass index [55] . 
 
This was further confirmed by the case control study 
conducted by Kim et al., who compared 110 pediatric cases with 
urolithiasis to 396 appropriately matched controls in his study and 
reported no association between high BMI and urolithiasis [56] .   
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In his study to identify the association of systemic 
conditions with urolithiasis in children, Kokorowski et al., used ICD 9 
codes to identify urolithiasis cases from 2004 to 2009, using Pediatric 
Health Information System Database. Diagnoses from all hospital 
encounters were ascertained for comorbid illnesses. Univariate and 
multivariable conditional logistic regression were used to assess the 
associations of urolithiasis with diabetes mellitus, hypertension and 
obesity. Among pediatric patients included in their study, urolithiasis is 
associated with higher odds of obesity and hypertension and lower odds 
of type I diabetes mellitus [57]. 
 
Thus it is clear that pediatric urolithiasis differs widely in 
different regions in various parameters. The results of 24 hour urine 
analysis for metabolic parameters are found to vary largely. However, the 
importance of deficiency of inhibitors in causing urolithiasis is recently 
well accomplished. Supplementation of inhibitors has proved beneficial 
in many trials. It must clearly be borne in mind that urolithiasis is just a 
symptom and the cause for it must definitely be sought for.  
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Materials and Methods 
STUDY DESIGN :  Prospective Descriptive study 
STUDY PLACE : Department of Pediatric nephrology, 
Institute of Child Health and Hospital for children,                                                                         
Egmore       
STUDY PERIOD : April 2014 – September 2014 
SAMPLE SIZE : 50 
CASE DEFINITION:   
All children with urinary tract calculi, presenting in the 
nephrology outpatient department of our hospital, satisfying the inclusion 
criteria were taken for the study. 
INCLUSION CRITERIA : 
All children between 1 month and 12 years  
 with the presence of a stone on imaging  by 
ultrasonography / Xray / CT scan 
 documented episode of  microscopic hematuria due to 
renal stone or passage of crystals in urine. 
EXCLUSION CRITERIA:  
Age < 1 month or > 12 years 
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MANOEUVRE: 
 Ethical committee and Scientific  committee approval 
were obtained before commencing the study. 
 Informed consent was obtained from the parents or the 
primary caregivers of the children. 
 All patients fitting the inclusion criteria were selected. 
 Detailed history regarding the presenting symptom, 
family history, mode of diagnosis and intervention 
performed was recorded. 
 If the child had urinary tract infection, the same was 
treated and then the child was evaluated for renal 
stones after a month. 
  Subjects who were on pharmacologic doses of 
vitaminD, calcium, antacids,diuretics, potassium citrate 
and vitamin C were asked to discontinue the 
medications for at least one 1 week, after which the 
metabolic evaluation was done. 
  An exception to this, is patients with distal renal 
tubular acidosis, where we could not discontinue drugs 
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for prolonged period, we admitted the children and 
discontinued the drugs under supervision. Though the 
cause for renal stones in distal renal tubular acidosis is 
already known as hypercalciuria and hypocitraturia, 24 
hour urinary metabolic evaluation was carried out.  
 If the child had undergone any surgical procedure, the 
child was evaluated 3 months later. 
 Ultrasonography and x-ray KUB were done for all 
patients with renal stones. For patients who had no 
finding of stone in ultrasonography but having strong 
suspicion of stone due to microscopic hematuria or 
renal colic, CT scanning was done. 
 About 3 ml of blood was collected for blood 
investigations comprising of renal function test, 
calcium, phosphorus, magnesium, alkaline 
phosphatase, uric acid. 
 If the child had abnormal calcium or phosphate levels, 
vitamin D and parathyroid hormone levels were 
measured. 
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 If renal tubular acidosis was suspected, then arterial 
blood gas analysis was done to document acidosis.   
 24 hour urine collection was done for measurement of 
citrate, calcium, oxalate and uric acid and the tests 
were done at main Apollo hospital laboratory, Chennai 
 Early morning urine pH was done for all patients . 
 To rule out cystinuria, urine sodium nitroprusside test 
was done for all patients and if it turned out to be 
positive, urine aminoacid chromatography was done to 
confirm the diagnosis.  
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NORMAL VALUES : 
 AGE RATIO 
SOLUTE/CREATININE 
24 HOUR 
URINE 
EXCRETION 
  
  CALCIUM  
0-6 months 
7-12 months 
≥2 years 
<0.8 mg/mg 
<0.6mg/mg 
<0.21 mg/mg 
<4 mg/kg/day 
 
  OXALATE  
0 to 6 months 
7 to 24 months 
2 – 5 years 
5 – 14 years 
>16 years 
288 to 260 mg/g 
110 to 139 mg/g 
80 mg/g 
60 to 65 mg/g 
32 mg/g 
<45 mg/1.73 
m2/day 
 
  CYSTINE  
< 1 month 
1-6 month 
>6 month 
<180 mg/g 
<112 mg/g  
<38 mg/g 
 
<60 mg/1.73 
m2/day 
 URIC ACID Term infant 
>3 years 
3.3 mg/dl GFR 
<0.53 mg/dl GFR 
<815 mg/1.73 
m2/day 
 
  CITRATE  
0 to 5 years 
>5 years 
>0.2 – 0.42 g/g 
>0.14 – 0.25 g/g 
> 0.14 g/1.73 
m2/day 
MAGNESIUM >2 years <0.12 mg/mg <88mg/1.73 
m2/day 
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Metabolic  evaluation  for renal stones comprises of  following  
investigations. 
IMAGING : 
  Ultrasonography 
  Plain Xray (KUB) 
  CT abdomen (as and when needed) 
  Intravenous pyelography (as and when needed) 
 
URINE : 
  In infants and nontoilet-trained patients, a random 
urine sample was checked for creatinine, calcium, uric 
acid, and oxalate levels. 
  In toilet trained patients, 24-hour urine was collected 
for the measurements of calcium, oxalate, uric acid and   
citrate.  
  Urine PH 
  Urine sodium nitroprusside test 
  Urine microscopy (routine / crystals ) 
  Urine culture 
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BLOOD : 
  Blood urea, s.creatinine, electrolytes 
  Calcium, phosphorus, magnesium 
  Alkaline phosphatase 
  Uric acid 
  PTH and Vitamin D (as and when needed) 
  Arterial blood gas analysis (as and when needed) 
 
RESULT ANALYSIS : 
  The statistical analysis was done using SPSS version 
15.0. 
  Descriptive statistics were computed for all 
biochemical variables,  for each of the diagnostic 
categories.  
  A two-tailed P-value <=0.05 was considered 
statistically significant.   
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RESULTS 
 
 
Our sample consisted of 50 children with age ranging 
from 2 months to 12 years. Mean age of presentation was 5.24 years 
(SD=3.28 yrs). 30 children were 5 year old or below. Out of these, 11 
children were 1 year old or below.  
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Fig 1: Age distribution of the study 
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Out of the 50 children included in our study, 17 were girls 
and 33 were boys. The following table shows the frequency and 
percentage of boys and girls in the study population. 
TABLE 1: 
      
 
 
        Fig 2. Gender distribution of the study population 
 
 Number (n= 50) Percentage (%) 
   Girls          17     34 
   Boys           33     66 
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The main presenting symptom was abdominal pain in 56 
%, dysuria in 44%. Hematuria was present in 38% of children in the 
study group. Fever was present in 26% of patients and flank pain in 16 % 
of children. 
 
TABLE 2 : 
Presenting symptom Frequency  (n=50) Percentage (%) 
Abdominal pain 28 56 
Dysuria  22 44 
Hematuria  19 38 
Fever  13 26 
Flank pain 8 16 
Vomiting 6 12 
Increased frequency of 
micturition/ dribbling 
6 12 
Growth retardation 2 4 
 
                               Results 
 
 
76 
 
  
 
 In children below 5 years, dysuria was the more 
predominant presenting complaint.  About 1/4th of the patients were 
asymptomatic and were diagnosed coincidentally during imaging for 
other reasons, or by microscopic hematuria or passage of crystals in 
urine. 5 patients in our study had passage of crystals in urine and stone 
analysis was done for those patients and 2 patients had microscopic 
hematuria.  
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Fig 3 : Predominant symptoms in the
study population 
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37 children had no family history of urolithiasis, whereas 
13 children had positive family history in parents, siblings or close 
relatives. 
TABLE 3: 
 Frequency (n=50) Percentage 
Family history 
present  
13 26 
Family history 
absent 
37 74 
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Ultrasonography of abdomen and KUB was done for all 
patients in our study group. Of the 50 children, 40 children had stones in 
the kidney, 3 children had stones in the ureter, 2 children had stones in 
the bladder, 3 children had stones in both kidney and ureter, and 2 
children had stones in both kidney and bladder. 
 
Location of calculi Frequency (n=50) Percentage (%) 
Kidney  40 80 
Ureter 3 6 
Bladder  2 4 
Kidney and ureter 3 6 
Kidney and bladder 2 4 
 
TABLE 4 :  
Table showing the frequency and percentage of stones at various  
 
locations  
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FIG 5 : Pie diagram showing the percentage distribution of stones in 
various locations. 
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It was also found that the out of the 40 patients with renal 
stones, the calculi were unilateral in 23 children and bilateral in 23 
children. In children with unilateral stones, right kidney calculi was in 14 
children and left kidney calculi was in 9 children. 
TABLE 5: 
 Frequency (n=50) Percentage 
Renal Stone- unilateral 23 46 
Renal Stone- bilateral 23 46 
 
 
 
Fig 6: Distribution showing the location of renal calculi 
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24 children had single calculi, whereas multiple calculi was 
found in 21 children. The mean stone size in our study population was 
8.93 mm (SD= 4.24mm) ranges from 3mm to 31mm. 13 patients had 
stone size < 5mm, 18 patients had stone size between 5 and 10 mm and 
12 patients    had  >10 mm stones.  
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This diagram shows the comparison of stone size in 
relation to gender in which the mean stone size of female was 9.27mm 
and in male it was 8.73mm with (p value=0.77)  which was greater than 
0.05 showing statistically insignificant relationship between gender and 
stone size. 
Fig 8 : Comparison of Stone size in relation to gender 
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Fig  9 :  Comparison of Stone size  with age of the patients 
 
This diagram shows the comparison of stone size in 
relation to age of the patients. They were categorized into three groups as 
0-3 yrs, 3-6 yrs,      <6 yrs. The mean stone size in 0-3 yrs was 8.38mm, 
3-6 yrs was 11.22 mm, <6mm was 8.19mm. The p value was found as 
0.38which was greater than 0.05 demonstrating that the relation between 
stone size and age is statistically insignificant . 
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            Ultrasonography also showed the presence of  
hydronephrosis / hydroureteronephrosis in 9 patients. Nephrocalcinosis 
was present in 4 of the children. 2 out of the 4 children with 
nephrocalcinosis had distal renal tubular acidosis. Anatomical 
abnormalities were present in 3 patients. 1 patient had horse-shoe kidney 
and 2 other patients had posterior urethral valves.  
 
 
18
Fig 10. Distribution showing the incidence of 
hydronephrosis in study population 
hydronephrosis 
present
hydronephrosis 
absent
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Stone analysis was done in 5 patients. All 5 had calcium 
stones, of whom 2 patients had calcium oxalate stones,1 patient had 
calcium oxalate and calcium carbonate stones, 1 had calcium oxalate and 
amorphous phosphate, 1 had calcium, uric acid, ammonia and phosphate 
stone.  
 
 
STONE ANALYSIS : 
TABLE 6: 
Stone analysis Number of patients 
(n =5) 
Calcium oxalate stones 2 
Calcium oxalate and calcium 
carbonate stones 
1 
Calcium oxalate and amorphous 
phosphate 
1 
Calcium, uric acid, ammonia and 
phosphate stone 
1 
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24 hour urinary metabolic workup was done in all patients 
of the study group and the results were as follows. 
Hyperoxaluria was present in 26 patients, of whom 12 
patients had hyperoxaluria alone while the rest 14 patients had mixed 
abnormalities. 
 Hypercalciuria was present in 16 patients totally, of 
whom only 4 patients had isolated hypercalciuria. In the rest 12 patients, 
mixed abnormalities were present.  
16 patients had hyperuricosuria, 5 of whom are pure 
hyperuricosuric, while the rest 11 are mixed.  
2 patients with nephrocalcinosis had hypercalciuria with 
hypocitraturia. These 2 patients also had low bicarbonate, normal anion 
gap metabolic acidosis and alkaline urine ph. A diagnosis of distal renal 
tubular acidosis was made in these 2 patients. 
The following table shows the distribution of patients 
based on various metabolic abnormalities. 
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TABLE 7 : 
  METABOLIC ABNORMALITY FREQUENCY PERCENT 
Hyperoxaluria 12 24.0 
Hypercalciuria 4 8.0 
Hyperuricosuria 5 10.0 
Hypocitraturia 5 10.0 
 Hypercalciuria/hyperoxaluria 5 10.0 
Hyperoxaluria/hyperuricosuria 4 10.0 
Hypercalciuria /hyperuricosuria 1 2.0 
Hypercalciuria/hyperoxaluria/hyperuricosuria 5 10.0 
 Hypercalciuria/ Hypocitraturia 2 4.0 
Idiopathic 3 6.0 
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COMPARISON OF PARAMETERS BETWEEN PATIENTS WITH 
HYPEROXALURIA AND HYPERCALCIURIA. 
HYPEROXALURIA : 
Out of 50 children included in our study, 26 children had 
hyperoxaluria. The mean age of presentation in patients with 
hyperoxaluria was 4.69 years with standard deviation of 2.72 years. 
Family history was positive in 23% of children with hyperoxaluria. Out 
of the 26 children, 15 were boys and 11 were girls. Mixed abnormalities 
were present in 14 children and isolated hyperoxaluria was present in 12 
children. 
TABLE 8 : 
PARAMETERS HYPEROXALURIA 
Number of patients 26 
Mean age of presentation 4.69 years ± 2.72 years 
Family history 23% 
Male : female ratio 15:11 
Mean Stone size in mm 7.42 mm ± 2.77 mm 
Mixed abnormalities 14 
 
                               Results 
 
 
90 
 
HYPERCALCIURIA : 
In our study population 17 children had hypercalciuria. 4 
children had hypercalciuria as an isolated abnormality, whereas 
remaining 13 children had mixed abnormalities with hypercalciuria as a 
component. Out of the 17 children, 8 were boys and 9 were girls. Mean 
age of presentation of children with hypercalciuria was  4.71 years with 
SD of 2.90 years. Family history was positive in 12.5 % of children with 
hypercalciuria. 
 
TABLE 9 : 
PARAMETER HYPERCALCIURIA 
Number of patients 17 
Mean age of presentation 4.71 years ± 2.90 years 
Family history 12.5% 
Male : female ratio 8:9 
Mean Stone size in mm 7.642mm ± 2.82 mm 
Mixed abnormalities 13 
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FIG 12: Bar chart showing the gender distribution of children with 
hyperoxaluria and hypercalciuria. 
 
When we compared the proportion of males and females in children with 
hyperoxaluria and hypercalciuria, there was no significant difference (p 
value =0.344) showing that the relation between gender and type of 
metabolic abnormality is insignificant. 
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Urine culture was positive in 2 patients, of whom one 
patient had E.coli growth and the other had proteus growth. None of the 
patients had family history of cystinuria / passage of cystine stones in 
urine. Urine sodium nitroprusside test was done in all patients and none 
of the patients had positive result.  
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DISCUSSION 
Urolithiasis is not an uncommon problem in childhood. 
Delay in the diagnosis or treatment of stone disease, may lead to damage 
of renal parenchyma and thus result in end stage renal disease. The true 
incidence of stone disease in Indian children has not been identified. 
Considering the volume of referred patients with urolithiasis to the 
pediatric outpatient department of our hospital, pediatric renal stone 
disease appears to be a disease of considerable burden. 
 
The mean age of our patients at presentation was 5.24 years 
± 3.28 years. In a study conducted in Iran with a population of 100 
children the mean age at presentation was 3.32 years. In our study group, 
30 children were 5 years old or below at presentation. Out of these, 11 
children were 1 year old or below. The wide demographic variation of 
patients with calculus disease may be due to the different climatic, 
genetic, dietary and socio-economic factors. 
 
Urolithiasis was detected more commonly in males, with the 
male to female ratio of 1.94:1. In most studies, the results were similar to 
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our study, with childhood renal calculus disease being more common in 
males. The male to female ratio of childhood renal calculus disease in 
different studies are found to be varying from 1.3:1 to 4:1. 
 
Pediatric urinary stone formers have a different pattern of 
presentation when compared to adults. While non-specific symptoms 
such as dysuria and irritability are commoner in infants, abdominal pain 
is the predominant presentation in children >5 years. Hematuria, fever 
and flank pain are other common symptoms noticed in our study 
population. This is similar to the study conducted in Iceland and other 
countries, who demonstrated abdominal pain to be the most common 
presenting symptom accounting for > 50 %. It would be difficult to 
identify typical renal colic in children as against in adults. 
 
In literature, the incidence of urinary tract infection in 
children with urolithiasis is reported to be between 8 % and 70 %. The 
rate of occurrence of urinary tract infection in our study population 
appears to be very low, when compared to these reported series. 
However, the actual role of UTI in urolithiasis is not clear, as the urinary 
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calculus can predispose the child to urinary infection by causing stasis, 
and conversely, UTI with urea splitting organisms can lead to formation 
of renal calculi such as magnesium ammonium phosphate stones.   
 
In this case study, the location of calculi was comparable to 
that reported from developed countries. 96 % of the calculi in our study 
population were in the upper urinary tract and 4 % of children had 
primary bladder calculus. This result is very close to the recent studies 
from other countries, which have reported much lower rates of calculus in 
the lower urinary tract. During the past few years, the pattern of calculus 
disease has changed, in many developing countries from a predominantly 
lower tract site towards the upper tract. 
In various studies from other countries, a positive family 
history of renal stone was reported in 11% to 21% of children. In our 
series, 26 % of children had a positive family history. This stresses the 
need for screening of family members especially sibling screening, in 
patients with renal stones, to diagnose stones at an early stage, thereby 
preventing the progression to renal failure.  
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The mean stone size of girls in our study population was 
9.27mm and in boys it was 8.73mm. The p value of the test comparing 
the relation of stone size to gender was 0.77, which is greater than 0.05 
showing statistically insignificant relationship between gender and stone 
size. 
 
24 hour urinary estimation of various metabolic parameters 
is, to date, the gold standard test for the metabolic evaluation of stone 
disease. Various levels of evidence propose that hypercalciuria is directly 
implicated in stone formation. The frequency of hypercalciuria in our 
study was 34 %.  This is in close agreement to the result obtained by 
Akhil joshi et al., from India who studied 39 subjects with urolithiasis and 
reported the frequency of hypercalciuria in their population to be 41%. 
Ismail Dursen et al., from Turkey reported the incidence of hypercalciuria 
to be 42.3%. However Mitra Naseri et al., from Iran and N.S. Hussain 
from Malaysia reported the incidence of hypercalciuria in their study to 
be 17 % and 14.6 % respectively. They attributed the low consumption of 
milk and milk products, low sodium intake or excessive sodium loss 
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through sweating as hot climate as possible causes for lesser incidence of 
hypercalciuria in their population. 
 
Urinary excretion of oxalate is an important factor 
determining the formation of urinary calculi. In our study 52 % of the 
children showed hyperoxaluria. This is similar to the result obtained from 
studies by NS Hussain et al from Malaysia and Akhil Joshi et al from 
India who showed the incidence of hyperoxaluria to be 61% and 56 % 
respectively. However, Mitra Naseri et al from Iran showed that the 
frequency of hyperoxaluria in their study was 11%. The higher incidence 
of hyperoxaluria in our population (52 %) may be due to genetic factors 
or high dietary oxalate intake or low calcium intake. Absence of 
colonization of the gut with Oxalobacter formigenes could also be a 
factor responsible for this high prevalence of hyperoxaluria in our 
children. Considering the significant family history associated with 
hyperoxaluria, genetic factors seem to be an important determinant 
responsible for the higher incidence of hyperoxaluria. 
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There are controversial data about the excretion of urinary 
citrate in stone formers. Deficiency of citrate which is an inhibitor of 
stone formation is an important factor causing stone formation. 
Hypocitraturia is found in 14% of our study population. However, from 
the study in north india by Akhil Joshi et al., and Kumar et al., it was 
concluded that hypocitraturia is the single most important contributor to 
stone formation. Kumar et al., also found that the value of citrate in urine 
of recurrent stone formers were much less when compared to first time 
stone formers. Nevertheless, the value of hypocitraturia in different 
studies are highly varying with a study from Iran reporting a frequency of 
2.1% and at the other end of the spectrum, study from India by Akhil 
Joshi reporting the incidence of hypocitraturia  to be 82%.  
 
In 34% of the children mixed abnormalities were found. 
10% of children had more than 2 metabolic abnormalities in urine. 2 
children had hypercalciuria and hypocitraturia, with ultrasound finding of 
nephrocalcinosis, with normal anion gap metabolic acidosis. The children 
were diagnosed to have distal renal tubular acidosis. 
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The finding of metabolic abnormality helps us to give a 
more specified treatment for the patients. Since there is a possibility of 
recurrence even after the surgical removal of stone, metabolic evaluation 
should be done for all patients, without which the treatment is 
incomplete.  
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CONCLUSION 
 
24 hour urine metabolic workup is the gold standard in 
metabolic evaluation of patients with urolithiasis. Whenever a stone is 
discovered, a thorough search must be undertaken in the hope of 
uncovering a specific metabolic cause. Hyperoxaluria followed by 
hypercalciuria was the most common metabolic abnormality detected in 
our pediatric population. Anatomic abnormality was detected in 6 % of 
children in our study group. Only 6% of children had no metabolic 
abnormality, underscoring the need for 24 hour urinary metabolic work 
up in all children with urolithiasis. An increasing number of children with  
stone disease undergo surgical treatment following which they think that 
the problem is over. They are not aware of the chances of recurrence and 
possibility of progression to end stage renal disease. Stress must be laid to 
explain to the parents the importance of metabolic work-up of stone 
disease and that recurrence and ESRD could be avoided by appropriately 
treating the metabolic abnormality, only then will they adhere to the 
medical treatment and dietary advice properly. 
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LIMITATIONS OF OUR STUDY : 
 Our Institute being a high volume tertiary care pediatric center, we 
were able to include sufficient number of urolithiasis cases in our 
study, though the incidence of urolithiasis in pediatric population is 
rare. However, this study is only a single-center study. A 
multi-center study would minimize selection bias. 
 We have not included a control group in our study.    
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RECOMMENDATIONS : 
 
1. 24 hour urine metabolic work-up should be done in all 
patients with urinary tract calculi. 
2. Screening of family members has to be done, whenever 
possible. 
3. Medical treatment appropriately suited for the child 
must be started even after the surgical removal of stone 
in order to prevent recurrence.  
Thus it must clearly be borne in mind that a stone in the 
urinary tract is mostly a sequelae to underlying metabolic or anatomic 
abnormality, and hence the cause for it should be aggressively looked for. 
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ABBREVIATIONS 
   
d- RTA                Distal renal tubular acidosis 
ARF Acute renal failure 
SIADH Syndrome of inappropriate anti 
diuretic hormone secretion 
IEM Inborn error of metabolism 
GSD Glycogen storage disease 
PUV Posterior urethral valves 
IBD Inflammatory bowel disease 
CT  Computerized tomography 
MAG 3  Mercapto-Acetyl-triGlycine  
ESWL Extra corporeal shock wave 
lithotripsy 
PCNL Per cutaneous nephrolithotomy 
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URS Ureteroscopic removal of stones 
RIRS Retrograde intrarenal surgery 
UTI Urinary tract infection 
BMI Body mass index 
ICD International classification of diseases 
USG Ultrasonography  
KUB Kidney-ureter-bladder 
SPSS Statistical Package for the Social 
Sciences 
SD Standard deviation 
SE Standard error 
E.coli Escherichia coli 
ESRD End stage renal disease 
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PATIENT DATA FORM 
 
STUDY TOPIC: METABOLIC EVALUATION IN RENAL STONE 
FORMERS 
 
Name : Age & sex : 
 
IP No : RC No : 
 
Address  :  Religion : 
 
History  
Abdominal pain Y N 
Gross hematuria Y N 
Nausea and vomiting Y N 
Fever Y N 
Flank pain Y N 
Abnormal urine colour  Y N 
Dysuria/cry during micturition  Y N 
                              Patient Data Form 
 
 
 
 
Dribbling and difficult voiding Y N 
Frequency of micturition Y N 
Growth retardation Y N 
Urinary retention  Y N 
Diagnosed by ultrasonography for different reasons  Y N 
Diagnosed by microscopic hematuria or crystal in urine  Y N 
Family h/o renal stones Y N 
Previous h/o similar complaints  Y N 
H/O intake of drugs like frusemide,antacids, vit D, vit C Y N 
H/O surgical intervention for the stone  Y N 
 
Dietary history 
                      
                              Patient Data Form 
 
 
 
 
Investigations 
 
 Ultrasonography of abdomen 
 
 Xray abdomen 
 
 CT abdomen 
 
 
S.urea S.creatinine S.sodium S.potassium S.bicarbonate 
     
 
S.Calcium S.Phosphorus S.Magnesium S.Alkaline 
Phosphatase 
S.Uric 
acid 
     
 
 PTH,25 OH vit D(as and when needed) 
 
 Urine routine 
                              Patient Data Form 
 
 
 
 
 
 
Albumin Sugar Deposits pH 
    
 
24 hour urinary Patient’s value Normal value 
Calcium   
Citrate   
Uric acid   
Oxalate   
              
Random urine Patient’s value Normal value 
calcium/creatinine   
citrate/creatinine                                         
uric acid/creatinine   
oxalate/creatinine   
                                          
 urine sodium nitroprusside test(cystine) 
 Arterial blood gas analysis and acid load test (as and when needed) 
 DIAGNOSIS : 
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